In Brief: Martek Biosciences
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences: Obtains patent for lower-cost source of long-chain polysaturated fatty acid DHA (docosahexaenoic acid) for use in infant formula, nutritional supplements and foods that "play a central role in the development of the eyes and central nervous system," the firm says Feb. 3. "Instead of processing Martek's DHA-rich algal biomass into DHA-rich oil, the biomass has the potential to be ingested directly by humans, commercial meat and egg producing animals and fish," Martek notes. Martek sells its DHA- containing nutritional oil in infant formulas in 21 countries ("The Tan Sheet" Dec. 22, 1997, p. 12)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning